Oct 20 (Reuters) – AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: BAYERN MUNICH ASSISTANT COACH AARON DANKS AND FORWARD SERGE GNABRY TALKING ABOUT ARSENAL…
WASHINGTON, Oct 20 - US President Donald Trump said on Tuesday that he will have…
FRANKFURT, Oct 20 (Reuters) - German sportswear maker Adidas on Tuesday raised its full-year profit…
By Wen-Yee Lee TAIPEI, Oct 20 (Reuters) - A union representing Micron Technology workers in…
By Christoph Steitz and Svea Herbst-Bayliss FRANKFURT/NEW YORK, Oct 20 (Reuters) - US activist investor…
VIDEO SHOWS: BAYERN MUNICH ASSISTANT COACH AARON DANKS AND FORWARD SERGE GNABRY TALKING ABOUT ARSENAL…